Scientists track experimental MS Drug's journey through the body
NCT ID NCT04171310
Summary
This early study aimed to understand how the body processes an experimental drug for multiple sclerosis (SAR442168). Six healthy male volunteers took a single, traceable dose so researchers could measure how much drug was absorbed, how it was broken down, and how it left the body. The main goal was to learn about the drug's safety and how it moves through the body, not to treat MS symptoms.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for MULTIPLE SCLEROSIS are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Investigational Site Number 8260001
Nottingham, United Kingdom
Conditions
Explore the condition pages connected to this study.